Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-FR Version v4-EN
Language French English
Date Updated 2023-08-04 2023-05-12
Drug Identification Number 02399016 02399016
Brand name BYSTOLIC BYSTOLIC
Common or Proper name Nebivolol Hydrochloride Nebivolol Hydrochloride
Company Name ABBVIE CORPORATION ABBVIE CORPORATION
Ingredients NEBIVOLOL NEBIVOLOL
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 tablets 30 tablets
ATC code C07AB C07AB
ATC description BETA BLOCKING AGENTS BETA BLOCKING AGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2023-03-24 2023-03-24
Estimated end date 2023-08-04 2023-06-09
Actual end date 2023-08-02
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments